Neuraxpharm and Panaxia Partner For Poland, After Germany And France
Companies Expect Sale Of Medical Cannabis-Based Product To Commence in First Half Of 2022
CNS specialist Neuraxpharm has announced expanding its strategic collaboration with Panaxia Labs Israel for advanced medical cannabis-based pharmaceutical products to Poland, after Germany and France. The companies expect sale of the cannabis portfolio to commence in the first half of 2022.
